2016
Explantation of infected aortic aneurysm and endograft with ascending aorta to mesenteric bypass for mesenteric ischemia
Gates L, Chin JA, Bonde PN, Chaar C, Sumpio BE, Sarac TP. Explantation of infected aortic aneurysm and endograft with ascending aorta to mesenteric bypass for mesenteric ischemia. Journal Of Vascular Surgery 2016, 65: 219-223. PMID: 27183855, DOI: 10.1016/j.jvs.2016.03.411.Peer-Reviewed Original ResearchMeSH KeywordsAgedAneurysm, InfectedAnti-Bacterial AgentsAortic Aneurysm, AbdominalAortographyBlood Vessel ProsthesisBlood Vessel Prosthesis ImplantationCeliac ArteryCoated Materials, BiocompatibleCollateral CirculationComputed Tomography AngiographyDevice RemovalEndovascular ProceduresHepatic ArteryHumansMaleMesenteric Artery, SuperiorMesenteric IschemiaMesenteric Vascular OcclusionProsthesis-Related InfectionsReoperationRifampinSplanchnic CirculationTreatment OutcomeConceptsAortic aneurysmBilateral renal arteriesSurgical revascularization techniquesSuperior mesenteric arteryAbdominal aortic aneurysmAxillobifemoral bypassGelsoft graftAbdominal painMesenteric ischemiaRevascularization techniquesThoracoabdominal aortaInferior mesentericMesenteric arteryRenal arterySurgical issuesMesenteric bypassAneurysmsAortaPrevious treatmentEndograftArteryBypassMesentericResectionIschemia
2015
Drug-Eluting Stents: New Tools for the Armamentarium Against Peripheral Arterial Disease.
Rajaee S, Hurtado CM, Sumpio B. Drug-Eluting Stents: New Tools for the Armamentarium Against Peripheral Arterial Disease. Surgical Technology Online 2015, 27: 200-7. PMID: 26680398.Peer-Reviewed Original ResearchMeSH KeywordsCoated Materials, BiocompatibleCytostatic AgentsDrug-Eluting StentsHumansNeovascularization, PathologicPeripheral Arterial DiseaseConceptsPeripheral arterial diseaseLower extremity peripheral arterial diseasePercutaneous transluminal angioplastyArterial diseaseComplications of PADOpen revascularization proceduresMainstay of treatmentEpidemic of diabetesCoronary artery diseaseLong-term outcomesInvasive endovascular proceduresDrug-coated stentsDrug-eluting stentsCardiac comorbiditiesTransluminal angioplastyArtery diseaseOpen revascularizationRestenosis rateRevascularization proceduresThrombosis rateEndovascular proceduresLower extremitiesHigher restenosisNeointimal hyperplasiaEconomic burden